Influence of molecular weight of chemically sulfated citrus pectin fractions on their antithrombotic and bleeding effects

被引:45
作者
Cipriani, Thales R. [1 ]
Gracher, Ana Helena R. [1 ]
de Souza, Lauro M. [1 ]
Fonseca, Roberto J. C. [2 ]
Belmiro, Celso L. R. [2 ]
Gorin, Philip A. J. [1 ]
Sassaki, Guilherme L. [1 ]
Iacomini, Marcello [1 ]
机构
[1] Univ Fed Parana, Lab Quim Carboidratos, Dept Bioquim & Biol Mol, BR-81531980 Curitiba, PR, Brazil
[2] Univ Fed Rio de Janeiro, Lab Tecido Conjunt, Hosp Univ Clementino Fraga Filho, Inst Bioquim Med, Rio De Janeiro, Brazil
关键词
Sulfated polysaccharide; citrus pectin; anticoagulant; antithrombotic; ANTICOAGULANT ACTIVITY; VENOUS THROMBOSIS; HEPARIN; ACTIVATION; DERIVATIVES; INHIBITION; ACCOUNT; FUCANS;
D O I
10.1160/TH08-08-0556
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Evaluated were the anticoagulant and antithrombotic activities, and bleeding effect of two chemically sulfated polysaccharides, obtained from citric pectin, with different average molar masses. Both low-molecular-weight (Pec-LWS, 3,600 g/mol) and high-molecular-weight sulfated pectins (Pec-HWS, 12,000 g/mol) had essentially the same structure, consisting of a (1 -> 4)-linked alpha-D-GalpA chain with almost all its HO-2 and HO-3 groups substituted by sulfate. Both polysaccharides had anticoagulant activity in vitro, although Pec-HWS was a more potent anti-thrombotic agent in vivo, giving rise to total inhibition of venous thrombosis at a dose of 3.5 mg/kg body weight. Surprisingly, in contrast with heparin, Pec-HWS and Pec-LWS are able to directly inhibit a-thrombin and factor Xa by a mechanism independent of antithrombin (AT) and/or heparin co-factor II (HCII). Moreover, Pec-HWS provided a lower risk of bleeding than heparin at a dose of 100% effectiveness against venous thrombosis, indicating it to be a promising antithrombotic agent.
引用
收藏
页码:860 / 866
页数:7
相关论文
共 29 条
[1]   Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels [J].
Berkowitz, DE ;
White, R ;
Li, DC ;
Minhas, KM ;
Cernetich, A ;
Kim, S ;
Burke, S ;
Shoukas, AA ;
Nyhan, D ;
Champion, HC ;
Hare, JM .
CIRCULATION, 2003, 108 (16) :2000-2006
[2]   AGGREGATION OF BLOOD PLATELETS BY ADENOSINE DIPHOSPHATE AND ITS REVERSAL [J].
BORN, GVR .
NATURE, 1962, 194 (4832) :927-&
[3]   GLYCOSAMINOGLYCANS AND THE REGULATION OF BLOOD-COAGULATION [J].
BOURIN, MC ;
LINDAHL, U .
BIOCHEMICAL JOURNAL, 1993, 289 :313-330
[4]   STRUCTURE AND BIOLOGICAL-ACTIVITY OF HEPARIN [J].
CASU, B .
ADVANCES IN CARBOHYDRATE CHEMISTRY AND BIOCHEMISTRY, 1985, 43 :51-134
[5]   A SIMPLE AND RAPID METHOD FOR THE PERMETHYLATION OF CARBOHYDRATES [J].
CIUCANU, I ;
KEREK, F .
CARBOHYDRATE RESEARCH, 1984, 131 (02) :209-217
[6]   Slight differences in sulfation of algal galactans account for differences in their anticoagulant and venous antithrombotic activities [J].
Fonseca, Roberto J. C. ;
Oliveira, Stephan-Nicollas M. C. G. ;
Melo, Fabio R. ;
Pereira, Maria G. ;
Benevides, Norma M. B. ;
Mourao, Paulo A. S. .
THROMBOSIS AND HAEMOSTASIS, 2008, 99 (03) :539-545
[7]   Serpin-independent anticoagulant activity of a fucosylated chondroitin sulfate [J].
Glauser, Bianca F. ;
Pereira, Mariana S. ;
Monteiro, Robson Q. ;
Mourao, Paulo A. S. .
THROMBOSIS AND HAEMOSTASIS, 2008, 100 (03) :420-428
[8]  
HIRSH J, 1992, BLOOD, V79, P1
[9]   New antithrombotic agents [J].
Hirsh, J ;
Weitz, JI .
LANCET, 1999, 353 (9162) :1431-1436
[10]  
Hoffman J., 1982, CARBOHYD POLYM, V2, P115, DOI [10.1016/0144-8617(82)90057-1, DOI 10.1016/0144-8617(82)90057-1]